REACH and CLP exemptions for defense in 2026: what changes for manufacturers and military suppliers

Key data

Manufacturers and suppliers of the defense industry in the EU have had a more flexible chemical regulatory framework since 21 October 2026. Regulation (EU) 2026/2382 modifies five major European regulations — REACH, CLP, Biocides, POPs and FED — to adapt their requirements to the specific needs of the military sector, in a geopolitical context that requires strengthening the European defense industrial and technological base (EDTIB).

The stated objective is to eliminate administrative burdens that slowed down production and investment in defense, without compromising overall chemical safety. For supplier companies, this represents an opportunity for operational simplification, but also the obligation to review which procedures now apply and which have been modified.

What does this regulation establish?

The Regulation simultaneously modifies five European reference standards in chemical and defense financing matters. Below are the specific changes by regulation:

The common thread of all these changes is the same: substances and products used exclusively in military applications may benefit from more flexible timelines and adapted requirements, reducing the bureaucratic burden that until now equated the defense sector with the rest of the chemical industry.

Economic and operational impact

The modification has a direct impact on the regulatory compliance costs of companies in the sector. Until now, a manufacturer of military components using substances subject to REACH had to follow exactly the same registration and authorization processes as any civil chemical company, with the same timelines and associated costs.

With the new framework, companies that can demonstrate the exclusively military use of their substances or products have access to:

• Total or partial exemptions in REACH registration processes.
• Simplified procedures in CLP classification and labeling.
• More flexible timelines for authorization of substances of very high concern (SVHC) in defense applications.
• Adapted requirements for biocides and persistent organic pollutants (POPs) for military use.
• Greater access to financing through the European Defense Fund (FED), with facilitated conditions.

The operational impact is especially relevant for companies managing dual-use substance portfolios — with civil and military use — as they will need to precisely delimit what part of their production can benefit from the new exemptions and what part remains under the general regime.

Who does it affect?

• Manufacturers of military equipment and material that use chemical substances regulated by REACH or CLP.
• Suppliers in the supply chain of defense contractors (Tier 1, Tier 2 and Tier 3).
• Companies that produce or import biocides for use in military facilities or equipment.
• Manufacturers working with persistent organic pollutants (POPs) in defense applications.
• Companies benefiting from or candidates for European Defense Fund (FED) financing.
• Regulatory Affairs, HSE and Procurement departments of industrial companies with defense contracts.
• Advisors and regulatory compliance consultants serving the aerospace, naval or land defense sector.

Practical example

A Spanish company manufacturing protection systems for armored vehicles uses several substances included in the REACH authorization list (Annex XIV) in its production process. Until October 2026, it had to request individual authorization for each substance, with the timelines and costs involved — a process that could extend for months and require significant technical and legal resources.

With Regulation (EU) 2026/2382 in force, this company can benefit from the simplified procedures introduced in REACH for substances for exclusively military use. This means it can review its portfolio of regulated substances, identify which ones are used only in defense contracts and request the application of the new regime, reducing both processing timelines and associated administrative costs. The critical step is to properly document and prove the exclusively military use of each substance.

What should companies do now?

1. Audit the inventory of regulated substances: Identify which substances under REACH, CLP, Biocides or POPs are used in the company and which have exclusively military application.
2. Delimit the scope of exemptions: Determine what part of production can benefit from the new simplified regime and what part remains under the general framework. Substances with dual use (civil and military) are not automatically exempt.
3. Update internal Regulatory Affairs procedures: Review registration, classification and authorization processes to incorporate the new timelines and adapted requirements.
4. Document exclusively military use: Prepare documentation that proves the military destination of substances or products to be able to invoke exemptions before the competent authorities.
5. Review FED financing opportunities: Analyze whether the modifications to Regulation (EU) 2021/697 open new avenues for access to European Defense Fund financing for ongoing or future projects.
6. Inform the supply chain: Communicate the changes to suppliers and subcontractors who may also be affected by the new exemptions or who must adapt their substance documentation.

Official source

Consult complete regulation in official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602382